NCT03169738 2025-02-21QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsImmunityBio, Inc.Phase 1/2 Withdrawn
NCT00643318 2021-03-05CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung CancerAccuray IncorporatedPhase 2 Unknown40 enrolled